Form 8-K

8-K — SS Innovations International, Inc.

Accession: 0001213900-26-046888

Filed: 2026-04-23

Period: 2026-04-23

CIK: 0001676163

SIC: 3841 (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS)

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — ea0287440-8k_ssinnova.htm (Primary)

EX-99.1 — PRESS RELEASE, DATED APRIL 23, 2026 (ea028744001ex99-1.htm)

GRAPHIC (ea028744001_ex99-1img1.jpg)

GRAPHIC (ea028744001_ex99-1img2.jpg)

GRAPHIC (ea028744001_ex99-1img3.jpg)

GRAPHIC (ea028744001_ex99-1img4.jpg)

GRAPHIC (ea028744001_ex99-1img5.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0287440-8k_ssinnova.htm · Sequence: 1

false

0001676163

2026-04-23

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

Pursuant to Section 13 or 15(d) of The Securities

Exchange Act of 1934

Date of report (Date of earliest event reported):

April 23, 2026

SS INNOVATIONS INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

Florida

001-42615

47-3478854

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

405, 3rd Floor, iLabs Info Technology Centre

Udyog Vihar, Phase III

Gurugram, Haryana India

122016

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including

area code: +91 73375 53469

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General

Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b)

of the Act:

Title of each Class

Trading Symbol

Name of each exchange on which registered

Common Stock

SSII

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the

Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

As used in this Current Report on Form 8-K (this “Current

Report”), the terms “SSi,” “the Company,” “we,” “us”

and “our” refer to SS Innovations International, Inc. and its subsidiaries.

Item 7.01 Regulation FD Disclosure.

On April 23, 2026, SSi issued a press release

announcing that the Company unveiled its vision for several cutting-edge surgical robotic technologies at the 2026 Global Multi-Specialty Robotic Surgery Conference, (which the Company recently hosted in New Delhi, India.

A copy of the press release is included with this

Current Report as Exhibit 99.1.

The information set forth in this Item 7.01

and contained in or linked to the press release included as Exhibit 99.1 to this Current Report, are deemed to be “furnished”

and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange

Act”), or otherwise subject to the liabilities of that Section. The information set forth in this Item 7.01 and contained

in or linked to the press release included as Exhibit 99.1 to this Current Report, shall not be deemed incorporated by reference

into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in

such filing.

Forward-Looking Statements

This Current Report and the press release included

as Exhibit 99.1 to this Current Report (including information linked to the press release), contain statements that are not historical

facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements

include all statements that are not historical statements of fact and statements regarding the Company’s intent, belief or expectations,

including, but not limited to, statements regarding the Company’s product developments, clinical and regulatory timelines, market

opportunity, competitive position, present possible or assumed future results of operations and other statements that are predictive in

nature. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,”

“will,” “intend,” “may,” “plan,” “project,” “should,” “could,”

“seek,” “designed,” “potential,” “forecast,” “target,” “objective,”

“goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements

relate to future events or SSi’s future financial performance and involve known and unknown risks, uncertainties and other factors

that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results,

levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance

on forward-looking statements.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

99.1*

Press Release, dated April 23, 2026

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

Furnished not filed

SIGNATURES

Pursuant to the requirements of the Securities

Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: April 23, 2026

SS INNOVATIONS INTERNATIONAL, INC.

By:

/s/ Sudhir Srivastava

Sudhir Srivastava, M.D.

Chairman and Chief Executive Officer

EX-99.1 — PRESS RELEASE, DATED APRIL 23, 2026

EX-99.1

Filename: ea028744001ex99-1.htm · Sequence: 2

Exhibit 99.1

SS Innovations Unveils Cutting-Edge Surgical

Robotic Technologies at SMRSC 2026

Innovations under development by Company include

the SSi Vimana Aero, SSi Avtara and SSi Operion

Fort

Lauderdale, FL – April 23, 2026 – SS Innovations International, Inc. (the “Company” or “SS

Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable

and accessible to a global population, today announced that the Company has unveiled its vision for several cutting-edge surgical robotic

technologies at the Global Multi-Specialty Robotic Surgery Conference (“SMRSC 2026”), which the Company recently hosted in

New Delhi, India. Key innovations under development by the Company and showcased at SMRSC 2026 include the SSi Vimana Aero Drone System

(the “SSi Vimana Aero”), the SSi Avtara Humanoid Surgical Platform (the “SSi Avtara”), the SSi Operion Mobile

Operating Room (the “SSi Operion”), and new single-arm robotic endoscopy and ultrasound assist carts.

The SSi Vimana Aero is a surgical robotic system currently under

development and designed to bring expert robotic surgical care directly to wounded soldiers in active battle zones, bridging the critical

time gap between initial point of injury and eventual medical evacuation from the frontlines. Deployed via a heavy-lift autonomous drone,

the SSi Vimana Aero can land in proximity to the casualty and deploy two miniature robotic arms with seven degrees of freedom. A trauma

surgeon then can remotely operate the SSi Vimana Aero, which is equipped with 5-millimeter surgical instruments, through an SSi Mantra

surgeon command center. The SSi Vimana Aero platform is intended to address hemorrhaging, wound repair, chest decompression, shrapnel

extraction, and field suturing, among other procedures, to help stabilize patients until evacuation teams arrive.

(Depiction of the SSi Vimana Aero Drone System)

The SSi Avtara, another innovation under conceptual development, aims to leverage the advanced mobility, dexterity, and perception capabilities of humanoid systems for high-impact surgical robotic applications spanning healthcare, defense, logistics, disaster response, and industrial settings. Integrated with artificial intelligence, teleoperation frameworks, and real-time sensing, the SSi Avtara will be designed for trainability, continuous learning, adaptability, and precision in the field. From assisting clinical workflows to operating in hazardous or otherwise inaccessible environments, the Company anticipates that the platform's human-compatible design will enable seamless interaction with existing infrastructure and tools.

(Depiction of the SSi Avtara Humanoid Robot)

The SSi Operion, also currently under development, is a fully

mobile, platform-agnostic operating room ecosystem designed for seamless deployment across hospitals, remote locations, combat areas,

and disaster zones. The SSi Operion is designed to be built on a wheeled chassis with overhead-integrated robotics and a zero-footprint

architecture, which seeks to eliminate conventional spatial constraints by suspending all surgical components from an integrated overhead

system, enabling 360-degree clinician access, real-time reconfiguration, and seamless deployment. With integrated telesurgery capabilities

and low-latency connectivity, the SSi Operion is expected to enable expert surgeons to operate remotely, expanding access to advanced

surgical care across geographies. From defense operations to humanitarian missions and rural healthcare delivery, SS Innovations believes

that SSi Operion holds potential to transform the operating room into a deployable, mission-ready asset.

(Depiction

of the SSi Operion Mobile Operating Room)

The Company’s new single-arm robotic endoscopy

and ultrasound assist carts, currently proceeding through early clinical validation phases in India, are designed to provide stable,

precise, and repeatable positioning of endoscopic and ultrasound instruments within clinical environments, bringing robotic consistency

to workflows. Operating under direct clinician supervision, the robotic arms incorporate controlled speed, force limits, and predictable

motion behavior, ensuring safe interaction with both patients and operators. Compatibility with standard hospital infrastructure and existing

clinical workflows allows for seamless integration into established clinical settings.

(SS Innovations’ single-arm robotic assist cart)

For a video clip of these and other new advancements

underway at SS Innovations, along with the Company’s existing surgical robotic technologies, please visit: https://youtu.be/oO-yoo82pfE.

Dr. Sudhir Srivastava, Chairman of the Board and

Chief Executive Officer of SS Innovations, commented, “Innovation is in our DNA. Beyond continuously improving our advanced, cost-effective

SSi Mantra surgical robotic system and telesurgery capabilities, we strive to pioneer new surgical robotic technologies that will meaningfully

improve healthcare for a wider segment of patients in need. SMRSC 2026, our largest conference yet, successfully elevated this important

theme.”

Recap of SMRSC 2026

SMRSC 2026 brought together distinguished surgeons,

global thought leaders, educators, and prominent healthcare innovators to discuss and shape the future of robotic surgery. Attendance

at SMRSC 2026 surpassed that of last year’s conference, drawing more than 1,600 attendees and 1,800 virtual participants from 19

nations. In addition to unveiling new surgical robotic technologies and groundbreaking concepts at SMRSC 2026, SS Innovations showcased

the SSi Mantra’s capabilities. At the conference, expert physicians conducted 10 live telesurgeries and 13 live robotic surgeries

across multiple specialties utilizing the SSi Mantra. The three-day event also featured dozens of panel discussions spanning specialties,

including urology, thoracic, gastroenterology, head & neck, gynecology, colorectal, general and pediatric, among others, with separate

cardiac-focused breakout sessions. Prominent guests and presenters at this year’s conference included, among others, the Company’s

Vice-Chairman, Dr. Fred Moll, who has been widely recognized as the “Father of Robotic Surgery”; Shri Pratap Rao Jadhav, the

Minister of State for Health and Family Welfare of India; Sri Madhusudan Sai, a global humanitarian and founder of a worldwide free healthcare

mission; and Dr. Mylswamy Annadurai, Former Director, ISRO Satellite Center.

About SS Innovations

SS Innovations International, Inc. (Nasdaq: SSII)

develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a

larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical

robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic

procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of

its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com

or LinkedIn for more information and updates.

About the SSi Mantra

The SSi Mantra surgical robotic system is a user-friendly,

modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command

center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic

patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana Tele Surgeon

Console is a portable, compact alternative to the SSi Mantra’s standard surgeon command center that provides equivalent control

functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40

different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments

for the pediatric population and ENT surgeries. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon

to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 100 different types of surgical

procedures.

Forward Looking Statements

This press release may contain statements that

are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.

The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,”

“intend,” “may,” “plan,” “project,” “should,” “could,” “seek,”

“designed,” “potential,” “forecast,” “target,” “objective,” “goal,”

or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future

events or SS Innovations’ future financial performance and involve known and unknown risks, uncertainties and other factors that

may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels

of activity, performance or achievements expressed or implied by these forward-looking statements.

Investor Contact:

The Equity Group

Kalle Ahl, CFA

T: (303) 953-9878

kahl@theequitygroup.com

Devin Sullivan, Managing Director

T: (212) 836-9608

dsullivan@theequitygroup.com

Media Contact:

RooneyPartners LLC

Kate Barrette

T: (212) 223-0561

kbarrette@rooneypartners.com

GRAPHIC

Filename: ea028744001_ex99-1img1.jpg · Sequence: 3

Binary file (4519 bytes)

Download ea028744001_ex99-1img1.jpg

GRAPHIC

Filename: ea028744001_ex99-1img2.jpg · Sequence: 4

Binary file (6644 bytes)

Download ea028744001_ex99-1img2.jpg

GRAPHIC

Filename: ea028744001_ex99-1img3.jpg · Sequence: 5

Binary file (5112 bytes)

Download ea028744001_ex99-1img3.jpg

GRAPHIC

Filename: ea028744001_ex99-1img4.jpg · Sequence: 6

Binary file (10779 bytes)

Download ea028744001_ex99-1img4.jpg

GRAPHIC

Filename: ea028744001_ex99-1img5.jpg · Sequence: 7

Binary file (8396 bytes)

Download ea028744001_ex99-1img5.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 12

v3.26.1

Cover

Apr. 23, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Apr. 23, 2026

Entity File Number

001-42615

Entity Registrant Name

SS INNOVATIONS INTERNATIONAL, INC.

Entity Central Index Key

0001676163

Entity Tax Identification Number

47-3478854

Entity Incorporation, State or Country Code

Entity Address, Address Line One

405, 3rd Floor

Entity Address, Address Line Two

iLabs Info Technology Centre

Entity Address, Address Line Three

Udyog Vihar, Phase III

Entity Address, City or Town

Gurugram

Entity Address, Country

Entity Address, Postal Zip Code

122016

City Area Code

+91

Local Phone Number

73375 53469

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock

Trading Symbol

SSII

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 3 such as an Office Park

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine3

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

ISO 3166-1 alpha-2 country code.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCountry

Namespace Prefix:

dei_

Data Type:

dei:countryCodeItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration